Mumbai reported its first case of Guillain-Barre Syndrome (GBS) on Friday, with a 64-year-old woman diagnosed with the rare ...

The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Mumbai has reported its first case of Guillain-Barré Syndrome (GBS), a rare nerve disorder, with a 64-year-old woman diagnosed on Friday. PTI reported According to Brihanmumbai Municipal Corporation ...

Mumbai has reported its first case of Guillain-Barre Syndrome (GBS), with a 64-year-old woman being diagnosed with the rare ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

With 38 wickets to his name, including five five-wicket hauls at an average of 13.45, he stands tall as this season’s ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Maharashtra reports a significant increase in Guillain-Barre Syndrome cases, with 170 suspected and 132 confirmed. State ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

1Sanford Research, Cancer Biology and Immunotherapies Group, Sioux Falls, South Dakota. 2Sanford School of Medicine, Health Sciences Center, University of South Dakota, Sioux Falls, South Dakota.